A retrospective, observational study switching to Toujeo vs other basal insulins in senior adults with type 2 daiabetes.
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2017
Price : $35 *
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms DELIVER 3
- 15 Jun 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
- 10 Jun 2017 According to a Sanofi media release, results were presented at the American Diabetes Association (ADA) 77th Scientific Sessions Annual Meeting.